NDI-219216
/ Nimbus Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 03, 2025
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
(clinicaltrials.gov)
- P1/2 | N=134 | Recruiting | Sponsor: Nimbus Wadjet, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Microsatellite Instability • Oncology • Solid Tumor
March 27, 2025
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients with Advanced Solid Tumors.
(clinicaltrials.gov)
- P1/2 | N=134 | Not yet recruiting | Sponsor: Nimbus Wadjet, Inc.
New P1/2 trial • Microsatellite Instability • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1